VBIV stock forecast
Our latest prediction for VBI Vaccines, Inc.'s stock price was made on the Sept. 23, 2019 when the stock price was at 0.51$.
In the short term (2weeks), VBIV's stock price should outperform the market by 7.58%. During that period the price should oscillate between -9.80% and +23.09%.
In the medium term (3months), VBIV's stock price should outperform the market by 16.80%. During that period the price should oscillate between -19.84% and +67.36%.Get email alerts
About VBI Vaccines, Inc.
VBI Vaccines, Inc. is a biopharmaceutical company, which engages in the development of vaccines for infectious disease and immuno-oncology. Its pipeline include HBV Therapeutic,HBV Prophylaxis, CMV Propylaxis, GBM Immunotherapy, MB Immunotherapy, and Zika Propylaxis. The company was founded on July 9, 2015 is headquartered in Cambridge, MA.
At the moment the company generates 4M USD in revenues.
On its last earning announcement, the company reported a loss of -0.80$ per share.
The book value per share is 1.39$
Three months stock forecastSept. 23, 2019
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|